Corvus Pharmaceuticals (CRVS) insider trading in the last 6 months
2 insiders bought $301K. No sales.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Who files at Corvus Pharmaceuticals
- Jeffrey Arcara
- David Scott Moore
Cluster buys at CRVS
2 insiders bought CRVS in the last 6 months: David Scott Moore and Jeffrey Arcara.
Questions about CRVS's insider trades
Are CRVS insiders buying or selling?
2 insiders bought $301K across 5 filings in the last 6 months. No open-market sales on record. The newest filing: Jeffrey Arcara, Chief Business Officer, bought $34K on Nov 11, 2026. 2 insiders bought CRVS in the last 6 months: David Scott Moore and Jeffrey Arcara.
Who are CRVS's biggest insider sellers?
No CRVS insider sold shares on the open market in the last 6 months, as filed on Form 4.
When did a CRVS insider last buy?
Jeffrey Arcara, Chief Business Officer, bought CRVS shares ($34K) on Nov 11, 2026, filed Nov 13, 2026, the newest insider buy on record.
Corvus Pharmaceuticals's page has its Quality Score, its chart, and its earnings. More in Healthcare and Biotech. CRVS is on insider buys, Nov 9 to 15, 2026.